Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-13
2006-06-13
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S490000
Reexamination Certificate
active
07060698
ABSTRACT:
The invention relates to benzoxazepinone derivatives of formulawhereinR1, R2, R3, R4, and n are as defined in the specification and to a pharmaceutically suitable acid addition salt thereof. These compounds are good γ-secretase inhibitors for the treatment of Alzheimer's disease.
REFERENCES:
patent: WO 01/98282 (2001-12-01), None
patent: WO 02/30912 (2002-04-01), None
Sisodia, S. S., et al., Nature Reviews Neuroscience vol. 3, Apr. 2002, pp. 281-290.
Wolfe, M. S., Current Topics in Medicinal Chemistry, 2002, vol. 2 pp. 371-383.
Tsai, J. Y. et al., Current Medicinal Chemistry, 2002, vol. 9, No. 11 pp. 1087-1106.
Sambamurti, K. et al., Drug Development Research, vol. 56, 2002, pp. 211-227.
May, P. C., Drug Discovery Today, vol. 6, No. 9, May, 2001, pp. 459-462.
Nunan, J. et al., FEBS Letters, vol. 483, 2000, pp. 6-10.
Hardy, J. et al., Science, vol. 297, Jul., 2002, pp. 353-356.
Wolfe, M. S., Journal of Medicinal Chemistry, vol. 44 No. 13, 2001, pp. 2039-2060.
Zhang, J. et al, J. Org. Chem. 1999, vol. 64, pp. 1074-1076.
Li, Y. M. et al., PNAS, vol. 97(11), 2000, pp. 6138-6143.
Brockhaus, M. et al., Neuroreport vol. 9(7), 1998, pp. 1481-1486.
Galley Guido
Goodnow, Jr. Robert Alan
Peters Jens-Uwe
Hoffmann-La Roche Inc.
Johnston George W.
Kifle Bruck
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
LandOfFree
Benzoxazepinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoxazepinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoxazepinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3628915